Arvinas, Inc. - Common Stock — 재무제표 (NASDAQ:ARVN) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 717.37 M1.58 B1.27 B1.3 B1.09 B717.9 M 총 부채 75.11 M799.9 M703.9 M644.6 M529.7 M284 M 자본금 총액 642.26 M781.7 M564.9 M660 M561.7 M433.9 M 총 부채 및 주주자본 717.37 M1.58 B1.27 B1.3 B1.09 B717.9 M 총부채 2 M1 M1 M800 K600 K600 K 순부채 2 M1 M1 M800 K600 K-685 M

뉴스

These Analysts Increase Their Forecasts On Arvinas After Q1 Results - Arvinas (NASDAQ:ARVN), Pfizer (NYSE

Arvinas, Inc. (ARVN) Q1 2026 Earnings Call Transcript

Arvinas: FDA Approval Validates The Platform, But Does Not Signal Near-Term Profitability

Arvinas, Inc. (ARVN) Reports Q1 Loss, Misses Revenue Estimates

Septerna, Inc. (SEPN) Reports Q1 Loss, Tops Revenue Estimates

Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates

Earnings Preview: ProQR (PRQR) Q1 Earnings Expected to Decline

Arvinas (ARVN) Moves 6.9% Higher: Will This Strength Last?

아비나스, 파킨슨병 치료제 ARV-102 임상시험 데이터 발표 예정

Arvinas to present ARV-102 Parkinson’s trial data at conference

Arvinas, Inc. (ARVN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

파이퍼샌들러, Arvinas 플랫폼 입증에 투자의견 재확인